| Peer-Reviewed

Description of Serotype 3 Dengue Fever Virus: Clinical, Surveillance and Geographical Expansion in the Northeastern Ethiopia, 2023

Received: 18 July 2023     Accepted: 9 August 2023     Published: 17 August 2023
Views:       Downloads:
Abstract

Dengue fever (DF) is emerging a mosquito-borne viral infection that commonly found in tropic and subtropic regions. It is caused by dengue virus, which is transmitted to human through the bites of infected with female Aedes mosquito during in the day time. Symptoms of DF includes high grade fever, headache, joint and muscle Paine, rash, and milled bleeding. dengue virus contains 4 different serotypes (DENV-1, DENV-2, DENV-3, and DENV-4). On April 4, 2023, a dengue fever (DF) outbreak in the Afar region was detected. From April 4 through June 26, 2023, there were over 6,133 cases reported, along with 4 facility Death were recorded. One hundred twenty tow cases (1.99%) were treated and managed in the inpatient department (IPD) and 64 cases had lab confirmation using RT-PCR from 154 suspected cases from the seven districts with the positivity rate was 41.6%. After 22 days had passed since dengue fever was confirmed in the area, a national response was deployed. Data from a line list compiled by the Afar Public Health and Research Institute from private and public health facilities between April 4 and June 26, 2323, was analyzed. Therefore, the objective of this analysis is to outline and emphasize the effect of DF in Afar, Ethiopia. The total attack rate was 11.91 / 1000 population, while the case fatality rate was 0.6 / 1000 population. By 33.13/1000 population, Semera-logiya town had the most impact compared to the other districts and towns. In this study, men were 54.4% more affected than women. Ages 15 to 24 in both sexes were more affected than older age groups by 33.1%, followed by older age groups 25 to 34 by 29.1%. Fever, which was present in 98.4% of cases, was followed by joint pain (91.5%) while bleeding from orifices was (1.6%).

Published in Science Journal of Public Health (Volume 11, Issue 4)
DOI 10.11648/j.sjph.20231104.12
Page(s) 123-131
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2023. Published by Science Publishing Group

Keywords

Dengue Fever, Serotype 3, Clinical, Surveillance, Expansion, Northeastern, Ethiopia

References
[1] Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, Drake JM, Brownstein JS, Hoen AG, Sankoh O, Myers MF. The global distribution and burden of dengue. Nature. 2013 Apr 25; 496 (7446): 504-7.
[2] World Health Organization. Global strategy for dengue prevention and control 2012-2020.
[3] Gulland, A., WHO urges countries in dengue belt to look out for Zika. 2016, British Medical Journal Publishing Group.
[4] Gubler, D. J. J. T. i. m., Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century. 2002. 10 (2): p. 100-103.
[5] Kosasih, H., et al., The epidemiology, virology and clinical findings of dengue virus infections in a cohort of Indonesian adults in Western Java. 2016. 10 (2): p. e0004390.
[6] Ling LM, Wilder-Smith A, Leo YS. Fulminant hepatitis in dengue haemorrhagic fever. Journal of clinical virology. 2007 Mar 1; 38 (3): 265-8.
[7] World Health Organization. Dengue in Africa: emergence of DENV-3, Côte d’Ivoire, 2008. Weekly Epidemiological Record=Relevé épidémiologique hebdomadaire. 2009; 84 (11-12): 85-8.
[8] Franco, L., et al., Recent expansion of dengue virus serotype 3 in West Africa. 2010. 15 (7): p. 19490.
[9] AMERICA, L. and C. R. EDITION, The global burden of disease: generating evidence, guiding policy. 2010.
[10] Messina, J. P., et al., The current and future global distribution and population at risk of dengue. 2019. 4 (9): p. 1508-1515.
[11] World Health Organization. Ending the neglect to attain the Sustainable Development Goals: a road map for neglected tropical diseases 2021–2030.
[12] Amarasinghe, A., et al., Dengue virus infection in Africa. 2011. 17 (8): p. 1349.
[13] Gubler, D. J., Dengue viruses: their evolution, history and emergence as a global public health problem, in Dengue and dengue hemorrhagic fever. 2014, CABI Wallingford UK. p. 1-29.
[14] Messer, W. B., et al., Emergence and global spread of a dengue serotype 3, subtype III virus. Emerg Infect Dis, 2003. 9 (7): p. 800-9.
[15] Saxena, P., et al., Co-Circulation of Dengue Virus Serotypes in Delhi, India, 2005: Implication for Increased DHF/DSS. 2006.
[16] Kanakaratne, N., et al., Severe dengue epidemics in Sri Lanka, 2003–2006. 2009. 15 (2): p. 192.
[17] Dorji, T., et al., Diversity and origin of dengue virus serotypes 1, 2, and 3, Bhutan. 2009. 15 (10): p. 1630.
[18] Gubler, D., et al., Dengue 3 virus transmission in Africa. 1986. 35 (6): p. 1280-1284.
[19] Sharp, T. W., et al., Dengue fever in US Troops during operation restore hope, Somalia, 1992–1993. 1995. 53 (1): p. 89-94.
[20] Woyessa, A. B., et al., The first acute febrile illness investigation associated with dengue fever in Ethiopia, 2013: a descriptive analysis. 2014. 28 (3).
[21] Degife, L. H., et al., Factors associated with dengue fever outbreak in Dire Dawa administration city, October, 2015, Ethiopia-case control study. 2019. 19: p. 1-7.
[22] Gutu, M. A., et al., Another dengue fever outbreak in Eastern Ethiopia—An emerging public health threat. 2021. 15 (1): p. e0008992.
[23] Ahmed, Y. M. and A. A. J. C. A. J. P. H. Salah, Epidemiology of dengue fever in Ethiopian Somali region: retrospective health facility based study. 2016. 2 (2): p. 51-6.
[24] Mohammed Yusuf, A., N. J. R. M. Abdurashid Ibrahim, and H. Policy, Knowledge, attitude and practice towards dengue fever prevention and associated factors among public health sector health-care professionals: in Dire Dawa, eastern Ethiopia. 2019: p. 91-104.
[25] Sisay, C., et al., Detection of serotype 1-Dengue fever outbreak in Dire Dawa city, Eastern Ethiopia. 2022. 5 (1): p. 49-54.
[26] Mekuriaw, W., et al., Epidemiological, Entomological, and Climatological Investigation of the 2019 Dengue Fever Outbreak in Gewane District, Afar Region, North-East Ethiopia. 2022. 13 (11): p. 1066.
[27] Mesfin, Z., et al., Dengue Fever Outbreak Investigation in Werder Town, Dollo Zone, Somali Region, Ethiopia. 2022: p. 7207-7217.
[28] Ferede, G. J. E. J. o. H. and B. Sciences, Dengue Fever as an Emerging Health Concern in Ethiopia. 2019. 9 (1): p. 1-2.
[29] Health, E. F. M. o., Health and health related indicators. 2012.
[30] CSA, I., Central Statistical Agency (CSA)[Ethiopia] and ICF. Ethiopia Demographic and Health Survey 2016. Addis Ababa, Ethiopia, and Rockville, Maryland, USA: CSA and ICF; 2016. 2017.
[31] Pliego EP, Velázquez-Castro J, Eichhorn MP, Collar AF. Increased efficiency in the second-hand tire trade provides opportunity for dengue control. Journal of theoretical biology. 2018 Jan 21; 437: 126-36.
[32] Rehman, A. U., et al., Incidence of Dengue fever, serotypes, clinical features, and laboratory markers: a case study of 2019 outbreak at district Shangla, KP, Pakistan. 2022. 22 (1): p. 521-31.
[33] Alayu, M., et al., Epidemiological Description of Dengue Fever Outbreak in Kebridhar District, Somali Region, Ethiopia–2017.
[34] Ahmad, S., et al., To evaluate the epidemiological trend of dengue fever in a teaching hospital at district Swat Pakistan. 2014. 6: p. 78-81.
[35] Minh An, D. T. and J. J. G. h. a. Rocklöv, Epidemiology of dengue fever in Hanoi from 2002 to 2010 and its meteorological determinants. 2014. 7 (1): p. 23074.
[36] Ahmed, S., et al., The 2011 dengue haemorrhagic fever outbreak in Lahore-an account of clinical parameters and pattern of haemorrhagic complications. 2013. 23 (7): p. 463-7.
[37] Mukhtar, F., M. Salim, and A. J. J. o. A. M. C. A. Farooq, Outbreak of dengue fever in Lahore: study of risk factors. 2012. 24 (2): p. 99-101.
[38] Khan, J., A. J. I. J. o. F. Khan, and B. Stud, Incidence of dengue in 2013: dengue outbreak in District Swat, Khyber Pakhtunkhwa, Pakistan. 2015. 2 (1): p. 1-7.
[39] Massangaie, M., et al., Clinical and epidemiological characterization of the first recognized outbreak of dengue virus-type 2 in Mozambique, 2014. 2016. 94 (2): p. 413.
[40] Waldetensai, A., et al., Assessment of the Resting Behavior of Aedes aegypti During Dengue Fever Outbreak of Dire Dawa, Eastern Ethiopia. 2021. 8 (7): p. 25.
[41] Philbert, A. and J. Ijumba, Preferred breeding habitats of Aedes Aegypti (Diptera-Culicidae) Mosquito and its public health implicati ons in Dares Salaam, Tanzania. 2013.
Cite This Article
  • APA Style

    Chalachew Sisay, Alemayehu Tadesse, Fantahun Workie, Ajanaw Yizengaw, Abdu Ali, et al. (2023). Description of Serotype 3 Dengue Fever Virus: Clinical, Surveillance and Geographical Expansion in the Northeastern Ethiopia, 2023. Science Journal of Public Health, 11(4), 123-131. https://doi.org/10.11648/j.sjph.20231104.12

    Copy | Download

    ACS Style

    Chalachew Sisay; Alemayehu Tadesse; Fantahun Workie; Ajanaw Yizengaw; Abdu Ali, et al. Description of Serotype 3 Dengue Fever Virus: Clinical, Surveillance and Geographical Expansion in the Northeastern Ethiopia, 2023. Sci. J. Public Health 2023, 11(4), 123-131. doi: 10.11648/j.sjph.20231104.12

    Copy | Download

    AMA Style

    Chalachew Sisay, Alemayehu Tadesse, Fantahun Workie, Ajanaw Yizengaw, Abdu Ali, et al. Description of Serotype 3 Dengue Fever Virus: Clinical, Surveillance and Geographical Expansion in the Northeastern Ethiopia, 2023. Sci J Public Health. 2023;11(4):123-131. doi: 10.11648/j.sjph.20231104.12

    Copy | Download

  • @article{10.11648/j.sjph.20231104.12,
      author = {Chalachew Sisay and Alemayehu Tadesse and Fantahun Workie and Ajanaw Yizengaw and Abdu Ali and Jamal Yusuf and Ebise Abose and Daniel Tsega and Solomon Kinde and Henok Tadesse},
      title = {Description of Serotype 3 Dengue Fever Virus: Clinical, Surveillance and Geographical Expansion in the Northeastern Ethiopia, 2023},
      journal = {Science Journal of Public Health},
      volume = {11},
      number = {4},
      pages = {123-131},
      doi = {10.11648/j.sjph.20231104.12},
      url = {https://doi.org/10.11648/j.sjph.20231104.12},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.sjph.20231104.12},
      abstract = {Dengue fever (DF) is emerging a mosquito-borne viral infection that commonly found in tropic and subtropic regions. It is caused by dengue virus, which is transmitted to human through the bites of infected with female Aedes mosquito during in the day time. Symptoms of DF includes high grade fever, headache, joint and muscle Paine, rash, and milled bleeding. dengue virus contains 4 different serotypes (DENV-1, DENV-2, DENV-3, and DENV-4). On April 4, 2023, a dengue fever (DF) outbreak in the Afar region was detected. From April 4 through June 26, 2023, there were over 6,133 cases reported, along with 4 facility Death were recorded. One hundred twenty tow cases (1.99%) were treated and managed in the inpatient department (IPD) and 64 cases had lab confirmation using RT-PCR from 154 suspected cases from the seven districts with the positivity rate was 41.6%. After 22 days had passed since dengue fever was confirmed in the area, a national response was deployed. Data from a line list compiled by the Afar Public Health and Research Institute from private and public health facilities between April 4 and June 26, 2323, was analyzed. Therefore, the objective of this analysis is to outline and emphasize the effect of DF in Afar, Ethiopia. The total attack rate was 11.91 / 1000 population, while the case fatality rate was 0.6 / 1000 population. By 33.13/1000 population, Semera-logiya town had the most impact compared to the other districts and towns. In this study, men were 54.4% more affected than women. Ages 15 to 24 in both sexes were more affected than older age groups by 33.1%, followed by older age groups 25 to 34 by 29.1%. Fever, which was present in 98.4% of cases, was followed by joint pain (91.5%) while bleeding from orifices was (1.6%).},
     year = {2023}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Description of Serotype 3 Dengue Fever Virus: Clinical, Surveillance and Geographical Expansion in the Northeastern Ethiopia, 2023
    AU  - Chalachew Sisay
    AU  - Alemayehu Tadesse
    AU  - Fantahun Workie
    AU  - Ajanaw Yizengaw
    AU  - Abdu Ali
    AU  - Jamal Yusuf
    AU  - Ebise Abose
    AU  - Daniel Tsega
    AU  - Solomon Kinde
    AU  - Henok Tadesse
    Y1  - 2023/08/17
    PY  - 2023
    N1  - https://doi.org/10.11648/j.sjph.20231104.12
    DO  - 10.11648/j.sjph.20231104.12
    T2  - Science Journal of Public Health
    JF  - Science Journal of Public Health
    JO  - Science Journal of Public Health
    SP  - 123
    EP  - 131
    PB  - Science Publishing Group
    SN  - 2328-7950
    UR  - https://doi.org/10.11648/j.sjph.20231104.12
    AB  - Dengue fever (DF) is emerging a mosquito-borne viral infection that commonly found in tropic and subtropic regions. It is caused by dengue virus, which is transmitted to human through the bites of infected with female Aedes mosquito during in the day time. Symptoms of DF includes high grade fever, headache, joint and muscle Paine, rash, and milled bleeding. dengue virus contains 4 different serotypes (DENV-1, DENV-2, DENV-3, and DENV-4). On April 4, 2023, a dengue fever (DF) outbreak in the Afar region was detected. From April 4 through June 26, 2023, there were over 6,133 cases reported, along with 4 facility Death were recorded. One hundred twenty tow cases (1.99%) were treated and managed in the inpatient department (IPD) and 64 cases had lab confirmation using RT-PCR from 154 suspected cases from the seven districts with the positivity rate was 41.6%. After 22 days had passed since dengue fever was confirmed in the area, a national response was deployed. Data from a line list compiled by the Afar Public Health and Research Institute from private and public health facilities between April 4 and June 26, 2323, was analyzed. Therefore, the objective of this analysis is to outline and emphasize the effect of DF in Afar, Ethiopia. The total attack rate was 11.91 / 1000 population, while the case fatality rate was 0.6 / 1000 population. By 33.13/1000 population, Semera-logiya town had the most impact compared to the other districts and towns. In this study, men were 54.4% more affected than women. Ages 15 to 24 in both sexes were more affected than older age groups by 33.1%, followed by older age groups 25 to 34 by 29.1%. Fever, which was present in 98.4% of cases, was followed by joint pain (91.5%) while bleeding from orifices was (1.6%).
    VL  - 11
    IS  - 4
    ER  - 

    Copy | Download

Author Information
  • Ethiopian Public Health Institute, Addis Ababa, Ethiopia

  • Ethiopian Public Health Institute, Addis Ababa, Ethiopia

  • Ethiopian Public Health Institute, Addis Ababa, Ethiopia

  • Ethiopian Public Health Institute, Addis Ababa, Ethiopia

  • Afar Public Health and Research Institute, Semera, Ethiopia

  • Afar Public Health and Research Institute, Semera, Ethiopia

  • Ethiopian Public Health Institute, Addis Ababa, Ethiopia

  • Ethiopian Public Health Institute, Addis Ababa, Ethiopia

  • Ethiopian Public Health Institute, Addis Ababa, Ethiopia

  • Ethiopian Public Health Institute, Addis Ababa, Ethiopia

  • Sections